Reflecting work in the Tal-Gan Lab
Streptococcus cristatus, a commensal member of the oral microbiota and recently reclassified from Streptococcus oligofermentans, has emerged as a promising candidate in the pursuit of biotherapeutics targeting oral pathogens. A comprehensive...
Reflecting work in the Carik and Malins Labs
This comprehensive review from the labs of David Craik and Lara Malins at Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, at the University of Queensland, published in Biochemistry, highlights the powerful...
Reflecting work in the Schneider Lab
Published in the Journal of the American Chemical Society, researchers in the lab of Dr. Joel P. Schneider at NIH, have unveiled a groundbreaking molecular design strategy that shifts gel-forming peptides into the crystalline state...
Reflecting work in the Arora Group
In a major step forward, researchers in the Arora Group at the New York University, have now developed a rationally designed proteomimetic receptor capable of selectively trapping MYC in its biologically active conformation...
Reflecting work in the Liu Lab
Published as an ASAP article in the Journal of the American Chemical Society, researchers from the Wenshe Liu Lab at Texas A&M, currenly our "Lab of the Month," present the development...
Reflecting work in the Mitchell Lab
Cyclopropane-containing amino acids, prized for their conformational rigidity and stability, are of increasing interest in therapeutic peptide development and antimicrobial drug discovery. A recent study from Nicholas Mitchell’s group at the University of Nottingham...
Reflecting work in the Woolfson Lab
The Woolfson Lab continues to break new ground in de novo protein design with the successful creation of mixed-charge A3B3 heterohexameric α-helical barrels, αHBs, assembled from distinct acidic, A, and basic, B, peptide chains. Drawing on...
Reflecting work in the Niitsu Lab
Membrane-spanning peptides that form ion-conductive channels remain a challenging frontier in de novo protein design. While strides have been made in creating water-soluble peptide assemblies, translating that precision to transmembrane systems...
Reflecting work in the D'Amelio Lab
As antibiotic resistance surges worldwide, the search for effective new therapeutics has led scientists to a surprising source: the venom of Bungarus fasciatus, the banded krait. From this venom, researchers have isolated Cathelicidin-BF...
Reflecting work in the Tezcan Group
Isopeptide bonds, IPBs, — covalent linkages between the side chains of lysine and asparagine/glutamine or aspartate/glutamate — are remarkable for their chemical resilience and structural significance...
Reflecting work in the Raj Lab
The selective incorporation of post-translational modifications, PTMs, into proteins remains a key challenge in chemical biology, particularly for modifications like arginine carbonylation, which plays a crucial role...
Reflecting work in the Merck Labs
The total synthesis and process development of enlicitide decanoate, MK-0616, an orally bioavailable inhibitor of proprotein convertase subtilisin/kexin type 9, PCSK9, represents a major breakthrough in macrocyclic peptide...
Reflecting work in the Raj Lab
Understanding how proteins interact with biological metabolites is crucial for deciphering biological processes and advancing therapeutic strategies. This study focuses on a specific class of metabolites—α,β-unsaturated carbonyls, particularly acrolein-derived...
Reflecting work in the Deming Lab
Self-assembled polymeric vesicles that respond to biologically relevant stimuli have significant potential in drug delivery and synthetic biology. While many stimuli-responsive assemblies disassemble upon activation, invertible vesicles...
Reflecting work in the Suga & Vinogradov Labs
α,β-Dehydroalanine, ΔAla, is a highly reactive nonproteinogenic amino acid that serves as a versatile handle for modifying peptides, natural products, NPs, and proteins. While many ΔAla functionalization...
Reflecting work in the Phan Group
Ribosomally synthesized and post-translationally modified peptides, RiPPs, represent an expanding class of natural products distinguished by their extensive post-translational modifications. Among the enzymatic systems...
Reflecting work in the Hartrampf Lab
Solid-phase peptide synthesis, SPPS, and native chemical ligation, NCL, are powerful methods for obtaining peptides and proteins that are otherwise inaccessible...
Reflecting work in the Nowick Lab
Vancomycin, a cornerstone antibiotic for Gram-positive infections, faces diminishing efficacy due to the emergence of vancomycin-resistant Enterococci, VRE, and vancomycin-resistant...
Automated Peptide Synthesis
In this sponsored content by Gyros Protein Technologies, discover how automated systems revolutionize peptide production with enhanced efficiency and reproducibility.
The evolution from manual to automated solid-phase peptide synthesis, SPPS, has transformed research workflows, significantly reducing human error while enabling walk-away operations and parallel processing capabilities.
Advanced features like microfluidic design, induction heating, and real-time UV monitoring create optimal conditions even for challenging sequences, substantially improving yield and purity. This article shows you how to harness these innovations for your peptide research needs.
The Nicola D'Amelio Lab
The D’Amelio Lab is part of the Enzyme and Cell Engineering Unit, UMR 7025 CNRS, with active sites at Université de Picardie Jules Verne, UPJV, in Amiens and Université de Technologie de Compiègne, UTC, in Compiègne, France. Co-directed by Professors Karsten Haupt, Bérangère Avalle, and Catherine Sarazin, the lab is led by Professor Nicola D’Amelio and is internationally recognized for its work in structural biology, biomedicine, and peptide engineering.
Professor D’Amelio’s team is at the forefront of peptide-based research targeting antimicrobial resistance, cancer, and neurodegenerative disease. Their ADAPTABLE platform—an interactive database of antimicrobial peptides—guides the rational design of therapeutic peptides, while ongoing projects explore peptide interference in cancer signaling, microbiome-based delivery systems, and blood-brain barrier-penetrating therapeutics for Alzheimer’s.
Stay tuned for more lab features, and don’t miss the chance to get your lab featured!
Please contact Lars Sahl to get involved!
What Current Members Say
"The American Peptide Society is at the forefront of showcasing innovative research and emerging trends in the field. The symposiums are a combination of inspiration and knowledge, essential for all peptide enthusiasts in academia and pharma to stay ahead in peptide science."
Danny Chou
Assistant Professor of Pediatrics Endocrinology
Stanford University, School of Medicine
The American Peptide Society has for many years been central to advancing and promoting peptide research through activities such as regular symposiums, the Peptide Science Journal, and ongoing webinars and news highlights. These efforts are an essential contribution to the field which benefits both the academic and industrial communities.
Jon Collins
Director of Business Development
CEM
“Being a member of the American Peptide Society and attending the Peptide Symposium, one of the key asset of the society, I have gain new perspectives on emerging peptide technologies, and gain insights about current challenges from prominent peptide leaders. It is a great society for the education and professional development for our peptide scientist.”
Ved Srivastava
Ph.D., Vice President of Peptide Chemistry
Intarcia Therapeutics
Peptide Synthesis for Beginners
Explore this in-depth tutorial on peptide synthesis, featuring contributions from the APS Website Committee and other researchers in the field.
Free Membership
Membership is free and open to graduate and undergraduate students, postdocs, professionals, and retired professionals, with an interest in peptides or a related scientific field.
Our Journal
